Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yardena Samuels

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
ESMO Open|January 10, 2019
Cancer research in the era of immunogenomicsYochai Wolf, Yardena Samuels
Current Topics in Microbiology and Immunology|June 11, 2010
Oncogenic mutations of PIK3CA in human cancersYardena Samuels, Todd Waldman
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2018
Cancer Exome-Based Identification of Tumor Neo-Antigens Using Mass SpectrometryShelly Kalaora, Yardena Samuels
Seminars in Cancer Biology|February 12, 2019
PIK3CA in cancer: The past 30 yearsRand Arafeh, Yardena Samuels
Pigment Cell & Melanoma Research|October 22, 2009
TYRO3-mediated regulation of MITF: a novel target in melanoma?Udo Rudloff, Yardena Samuels
Current Opinion in Oncology|December 17, 2005
Oncogenic PI3K and its role in cancerYardena Samuels, Kajsa Ericson
Methods in Molecular Biology (Clifton, N.J.)|January 11, 2018
Analysis of Enzymatic Activity of Matrix Metalloproteinase (MMP) by Collagen Zymography in MelanomaVijay Walia, Yardena Samuels
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2022
Intratumor Heterogeneity and Antitumor Immunity Shape One Another BidirectionallyYochai Wolf, Yardena Samuels
Cell Cycle (Georgetown, Tex.)|April 21, 2010
A growing family: adding mutated Erbb4 as a novel cancer targetUdo Rudloff, Yardena Samuels
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2012
Molecular pathways: dysregulated glutamatergic signaling pathways in cancerTodd D Prickett, Yardena Samuels
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
ESMO Open|January 10, 2019
Cancer research in the era of immunogenomicsYochai Wolf, Yardena Samuels
Current Topics in Microbiology and Immunology|June 11, 2010
Oncogenic mutations of PIK3CA in human cancersYardena Samuels, Todd Waldman
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2018
Cancer Exome-Based Identification of Tumor Neo-Antigens Using Mass SpectrometryShelly Kalaora, Yardena Samuels
Seminars in Cancer Biology|February 12, 2019
PIK3CA in cancer: The past 30 yearsRand Arafeh, Yardena Samuels
Pigment Cell & Melanoma Research|October 22, 2009
TYRO3-mediated regulation of MITF: a novel target in melanoma?Udo Rudloff, Yardena Samuels
Current Opinion in Oncology|December 17, 2005
Oncogenic PI3K and its role in cancerYardena Samuels, Kajsa Ericson
Methods in Molecular Biology (Clifton, N.J.)|January 11, 2018
Analysis of Enzymatic Activity of Matrix Metalloproteinase (MMP) by Collagen Zymography in MelanomaVijay Walia, Yardena Samuels
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2022
Intratumor Heterogeneity and Antitumor Immunity Shape One Another BidirectionallyYochai Wolf, Yardena Samuels
Cell Cycle (Georgetown, Tex.)|April 21, 2010
A growing family: adding mutated Erbb4 as a novel cancer targetUdo Rudloff, Yardena Samuels
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2012
Molecular pathways: dysregulated glutamatergic signaling pathways in cancerTodd D Prickett, Yardena Samuels
Pageof 11